Vapotherm News

Piper Sandler Maintains Underweight on Vapotherm, Lowers Price Target to $1

BenzingaNov 9, 2023 14:45 ET

Vapotherm Analyst Ratings

BenzingaNov 9, 2023 14:44 ET

Vapotherm (VAPO) Receives a Sell From Piper Sandler

TipRanksAug 9, 2023 07:26 ET

Vapotherm (VAPO) Gets a Hold From BTIG

TipRanksMay 3, 2023 23:06 ET

Analysts Offer Insights on Healthcare Companies: Vapotherm (VAPO) and Nektar Therapeutics (NKTR)

TipRanksFeb 23, 2023 23:51 ET

Piper Sandler Adjusts Price Target on Vapotherm to $0.50 From $1, Maintains Underweight Rating

MT NewswiresFeb 13, 2023 22:31 ET

Vapotherm Analyst Ratings

Benzinga Analyst RatingsFeb 13, 2023 06:23 ET

Piper Sandler Maintains Underweight on Vapotherm, Lowers Price Target to $0.5

Benzinga Real-time NewsFeb 13, 2023 06:23 ET

BTIG Keeps Their Hold Rating on Vapotherm (VAPO)

TipRanksNov 3, 2022 09:50 ET

BTIG Remains a Hold on Vapotherm (VAPO)

TipRanksOct 3, 2022 18:40 ET

Vapotherm stock sheds ~31% as Q2 results disappoint, co cuts FY 2022 revenue guidance

Seeking AlphaAug 4, 2022 13:45 ET

Vapotherm Price Target Cut to $2.00/Share From $2.50 by Piper Sandler

Dow JonesAug 4, 2022 06:58 ET

Piper Sandler Maintains Underweight on Vapotherm, Lowers Price Target to $2

Benzinga Real-time NewsAug 4, 2022 06:48 ET

Vapotherm Cut to Market Perform From Outperform by William Blair

Dow JonesAug 4, 2022 06:26 ET

Vapotherm analyst ratings

Benzinga Analyst RatingsAug 4, 2022 06:16 ET

Piper Sandler Adjusts Vapotherm's Price Target to $2 From $2.50, Reiterates Underweight Rating

MT NewswiresAug 4, 2022 05:16 ET

What 6 Analyst Ratings Have To Say About Vapotherm

Benzinga Real-time NewsJun 24, 2022 12:04 ET

Vapotherm Price Target Cut to $7.00/Share From $9.00 by BTIG

Dow JonesJun 24, 2022 10:27 ET

Vapotherm Is Maintained at Buy by BTIG

Dow JonesJun 24, 2022 10:27 ET

BTIG Research Adjusts Vapotherm Price Target to $7 From $9, Maintains Buy Rating

MT NewswiresJun 24, 2022 10:21 ET